Verve Therapeutics, Inc. (VERV) Social Stream
Verve Therapeutics Inc (VERV) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Verve Therapeutics Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
VERV's average price target has moved down $5.5 over the prior 124 days.
VERV reports an average of 44.17% for its upside potential over the past 26 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
VERV Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 61 days, VERV's average broker recommendation rating improved by 0.13.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- VERV has a greater upside potential (average analyst target price relative to current price) than 239.49% of all US stocks.
- In terms of how Verve Therapeutics Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -130.61% of that group.
- Verve Therapeutics Inc's average analyst price target is greater than 241.44% of Pharmaceutical Products stocks.
- VERV has a greater number of analysts covering the stock than 101.27% of stocks in the mid market cap category.
What is the outlook for VERV? Use POWR Ratings for clearer insight into price direction.